Silverarc Capital Management, LLC Praxis Precision Medicines, Inc. Transaction History

Silverarc Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.87 - $1.71 $558,329 - $1.1 Million	641,758 Added 18.46%	4,117,920 $7.04 Million
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $2.89 Million - $4.1 Million	3,476,162 New	3,476,162 $4 Million
Q4 2022 Feb 14, 2023	SELL	$1.88 - $36.45 $2,991 - $57,991	-1,591 Reduced 1.59%	98,409 $234,000
Q3 2022 Oct 28, 2022	BUY	$2.5 - $37.95 $250,000 - $3.8 Million	100,000 New	100,000 $227,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.